MedPath

ROLE OF SIMILLIMUM IN THE MANAGEMENT OF ATTENTION DEFICIT HYPERACTIVE DISORDER IN SCHOOL CHILDREN UP TO 12 YEARS

Phase 3
Conditions
Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined typeHealth Condition 2: F901- Attention-deficit hyperactivity disorder, predominantly hyperactive typeHealth Condition 3: F900- Attention-deficit hyperactivity disorder, predominantly inattentive type
Registration Number
CTRI/2021/11/037884
Lead Sponsor
Dr Siju V
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children diagnosed with ADHD.

Children between 6 to 12 years of age.

Exclusion Criteria

Children undergoing any other chronic treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Common Simillimum suited for the management of ADHD can be identified. 200th potency of simillimum is useful for ADHD.Timepoint: first 6 moths recruiting <br/ ><br>extended for another 6 months if required <br/ ><br>last one year followup assessment and analysis, report preparation <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Common type of ADHD prevalent in schools of Kanniyakumari Dist. will be identified.Timepoint: first 6 moths recruiting <br/ ><br>extended for another 6 months if required <br/ ><br>last one year followup assessment and analysis, report preparation <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath